Foundation for Angelman Syndrome

Medical research organization based in Austin, TX. 9 employees. Exempt under §501(c)(3).

MissionANGELMAN SYNDROME (AS) IS A NEURODEVELOPMENTAL DISORDER CHARACTERIZED BY GLOBAL DEVELOPMENT DELAYS AND SEVERE SPEECH IMPAIRMENT. A FEW INDIVIDUALS WITH AS DEVELOP FUNCTIONAL SPEECH, BUT MOST COMMUNICATE THROUGH A MIXTURE OF GESTURES, EYE GAZE, ADAPTED SIGN LANGUAGE AND

Financial snapshot · TY 2023

$6.5M
Total revenue
$23.2M
Total expenses
$58.4M
Net assets

Financial health · TY 2023

80
Strong financial health
Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.
Reserve ratio
100
20.6 months of expenses
Program efficiency
100
94.9% spent on programs
Revenue diversity
0
Mix of program fees, grants & contributions

Leadership compensation

Ryan K Fischer
CHIEF OPERATING OFICER
$198,051
62th percentile vs. peers
Kena Richert
CHIEF FINANCIAL OFFICER
$191,948
58th percentile vs. peers
Alana Newhouse
PRESIDENT/CEO
$177,800
29th percentile vs. peers

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.

Claim this page
Foundation for Angelman Syndrome Executive Compensation | 990 Data | DoubleNine